PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1932

  1. 590 Posts.
    lightbulb Created with Sketch. 64
    Yes well Morning Star is absolute rubbish.
    No real thought appears to go into their recommendation in my opinion.
    I can't see a sell recommendation in my morning star report? They have PAR undervalued at 2.29 as far as I can see.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.